A prospective controlled trial comparing xenograft/autogenous bone and collagen-stabilized xenograft for maxillary sinus augmentation-Complications, patient-reported outcomes and volumetric analysis.
Jamil AlayanSašo IvanovskiPublished in: Clinical oral implants research (2017)
MSA using a lateral wall approach is safe and associated with mild to moderate pain and restrictions to daily activities for 48-72 hr. Patients' reports of morbidity were greater with autogenous bone harvesting. Collagen-stabilized ABBM provides comparable bone volume to AB + ABBM that is sufficient for placement of implants of adequate size with no need for further vertical augmentation. Engaging the surrounding sinus walls had a significant positive impact on graft volume.
Keyphrases
- patient reported outcomes
- soft tissue
- bone mineral density
- end stage renal disease
- bone loss
- ejection fraction
- newly diagnosed
- chronic kidney disease
- bone regeneration
- chronic pain
- postmenopausal women
- pain management
- prognostic factors
- wound healing
- randomized controlled trial
- body composition
- open label
- study protocol
- tissue engineering
- minimally invasive
- spinal cord
- adverse drug
- energy transfer